Resonance Health Limited has disclosed a change in director's interest notice concerning David Fuller. The indirect interest held by D1 UK SMSF Pty Ltd, controlled by David Fuller, acquired 98,701 ordinary fully paid shares through an on-market purchase, valued at $3,962.99. There were no securities disposed of during this transaction.

The notice confirms that there were no trades conducted during a closed period, and no prior written clearance was required or provided for the transaction. Investors are encouraged to review the full details provided in the Appendix 3Y for a comprehensive understanding of the director's interest change.

If you have any questions regarding this announcement or require further clarification, please feel free to reach out to us. Your trust and confidence in our company are of utmost importance, and we are committed to transparency in all our dealings with our investors.